Clinical Trial Update: Safety of Anti-tumor Necrosis Factor (TNF) Monoclonal Antibodies in Inflammatory Bowel Disease

View source ↗

Summary

This clinical trial update reviews the safety of anti-TNF monoclonal antibodies in inflammatory bowel disease, including ulcerative colitis and Crohn's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Indeterminate Colitis
• Inflammatory Bowel Disease
• Ulcerative Colitis

Snippet

Sponsor: Maria Sklodowska-Curie National Research Institute of Oncology | Conditions: Inflammatory Bowel Disease, Ulcerative Colitis | Status: UNKNOWN